Advertisement

Topics

Encouraging Response Observed with Opdivo (nivolumab) Plus Investigational IDO1 Inhibitor, ...

02:06 EST 10 Nov 2017 | BioMedReports - Blog

Safety profile is consistent with that previously reported for the BMS-986205 plus Opdivo combination

Read more...

Original Article: Encouraging Response Observed with Opdivo (nivolumab) Plus Investigational IDO1 Inhibitor, ...

NEXT ARTICLE

More From BioPortfolio on "Encouraging Response Observed with Opdivo (nivolumab) Plus Investigational IDO1 Inhibitor, ..."

Advertisement
Quick Search
Advertisement
Advertisement